Healthcare | August 16, 2021
Apollo Hospitals PAT at Rs 489.28 cr. in Q1FY22
The hospital chain aggressively embarks on digitisation and is e-health ready
The hospital chain aggressively embarks on digitisation and is e-health ready
Five seats reserved for Wards of COVID warriors in central MBBS admission
Aditya Puri former MD of HDFC bank joins Solara board as chairman
It works as an adjunct to standard care based on robust clinical trials
Earlier, the USFDA has granted ‘Orphan Drug Designation’ and ‘Fast Track Designation’ to Saroglitazar Mg for PBC
Building upon the momentum gained by pharma sector during the pandemic, Indian Pharmaceutical Alliance is leaving no stone unturned to create a faster road to recovery.
Their feedback and the consequent changes in software/protocols based on those inputs were deliberated upon.
Subscribe To Our Newsletter & Stay Updated
